+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
From
From
From
From
From
From
Enzyme-linked Immunosorbent Assay (elisa) Market 2024-2028 - Product Thumbnail Image

Enzyme-linked Immunosorbent Assay (elisa) Market 2024-2028

  • Report
  • August 2024
  • 192 Pages
  • Global
From
Alpha Glucosidase Inhibitors Market 2024-2028 - Product Thumbnail Image

Alpha Glucosidase Inhibitors Market 2024-2028

  • Report
  • August 2024
  • 135 Pages
  • Global
From
Hormone Replacement Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Hormone Replacement Therapy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 194 Pages
  • Global
From
Hypodermic Needles Market 2025-2029 - Product Thumbnail Image

Hypodermic Needles Market 2025-2029

  • Report
  • July 2025
  • 213 Pages
  • Global
From
Injection Pen Market 2025-2029 - Product Thumbnail Image

Injection Pen Market 2025-2029

  • Report
  • August 2025
  • 223 Pages
  • Global
From
Diabetic Neuropathy Market Report 2026 - Product Thumbnail Image

Diabetic Neuropathy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator